ORAL Q-4 Panel Oral Fluid Drug Screen Device NON-DIAGNOSTIC FORENSIC USE ONLY* Marijuana (THC) • Cocaine (COC) • Methamphetamine (mAMP) • Opiates (OPI) The ORAL Q-4™ is the newest, simplest to use, improved accuracy, oral fluid (saliva) based, point of contact test screen for illicit and prescription drug use or abuse. Simple and discreet drug of abuse testing without the inconvenience, embarrassment or biological hazard risks associated with urine specimen collection and handling. Completely eliminates the possibility of sample contamination, adulteration, substitution or manipulation. For Forensic Use Only.

Saliva Drug tests also available in 5 Panel 6 Panel 12 Panel

PRINCIPLE

Incorporating a newly developed, patented collection device for human saliva samples, the ORAL Q-4™ is a self-contained, ready to use, point of contact drug testing device that detects four drugs (or drug classes) of abuse: Marijuana (THC), Cocaine, Opiates (or all opium based drugs) and Methamphetamine (and its derivatives) using the preferred lateral flow immunoassay technology for this method of test screening. The test requires no special training to complete and qualitative yes/no results are visibly obtained within ten (10) minutes and results are stable up to 1 hour.

Oral Fluid Assay System For Drugs of Abuse

For a comprehensive discussion on drug of abuse testing including typical detection time periods see the DRUG TESTING FAQ

The ORAL Q-4™ forensic drug testing system detects the four most commonly abused illicit drugs using a saliva sample. Because urine collection is not necessary, there are certain advantages using the ORAL Q-4™ system for on-site drug screening. Additionally, because the test subject is present for the entire sample collection and  testing process, the possibility of sample adulteration and/or substitution is eliminated. The ORAL Q-4™ will detect Marijuana (THC), Cocaine (COC), Opiate (OPI) and Methamphetamine (M-AMP) use at a sensitivity level for saliva concentration* according to the following chart:

* Sensitivity detection levels for oral fluid (saliva) are considerably lower than those for urine tests because the concentration of detectable drug metabolites are significantly less in oral fluids (saliva). The sensitivity cut-off levels above generally correlate with the standards established for forensic urine tests by the NIDA, SAMSHA and WHO. For a technical document on the precision and specificity of the ORALINE (formerly ORALscreen) saliva drug screen in relationship to urine based tests see the OralScreen Technical Whitepaper. 

Additionally, the Aimstep ORAL Q-4™ drug test will detect the  metabolites and chemical derivatives of the class of drugs noted above including all opium derivatives (codeine, heroin, etc.) and Methamphetamine (ecstasy, amphetamine, etc.) Other features of using the ORAL Q-4™ drug test include:

PROCEDURE:

The ORAL Q-4™ System is formulated for use with human oral fluid speci­mens (saliva). Confirm the expiration date printed on the test package. Do not open the test packages until you are ready to perform the drug screen assay. If, necessary, bring the test pouch to room temperature . Insure that the person being tested has had nothing in their mouth for at least 5 minutes before sample collection. This includes water or other beverages (dilution) or food of any type (contamination). Directly observe the person during sample collection.

1. Collect the oral fluid sample by removing the collector device from the package. Screw the collector cap counter clockwise and remove the collection sponge from the collection chamber.

2. Insert the sponge into the mouth of the test subject. Have the subject close their mouth and move the sponge around for approximately 3 minutes or until the sponge is soft and fully saturated with saliva. The sponge will be soft and free of hard spots when completely saturated with saliva. Remove the sponge device from the test subject's mouth and return it to the collection chamber.

3. Open the test cassette package and place the test cassette on a clean and level surface. Unscrew the collection device dispenser cap on the end of the collection chamber.

4. Hold the collector upright and point the opening of the dispenser toward the sample well of the test cassette device. Use the thumb and index finger to squeeze the collection chamber and dispense 1 drop of collected saliva (approximately 50μL) into each specimen well.

5. Observe visible migration of the saliva sample across the test window. If migration does not occur within a few minutes add an additional specimen drop to the well. Allow 10 minutes for complete test result development.

INTERPRETATION OF RESULTS

Wait 10 minutes for test results to fully develop. Test results are read by observing and scoring the pre-printed red/pink lines on the test result panel as present or absent, 15 minutes after the sample was added: Note: the graphic below is for illustration purposes only. The actual test device will vary from the pictures below however the result interpretation is the same.

NEGATIVE	POSITIVE M-AMP	POSITIVE THC/M-AMP	INVALID
A Negative test result is indicated by pink rose lines adjacent to each target drug label plus a control line.	A Positive test result is indicated by the absence of a pink rose line adjacent to the target drug label plus a control line.	A Positive multiple test result is indicated by the absence of pink rose lines adjacent to each target drug label plus a control line.	An Invalid test result is indicated by the absence of a pink rose line adjacent to the "C" or Control label regardless of results in the other labeled areas.

A NEGATIVE test result is indicated by the continued presence of a red/pink line adjacent to the labeled target drug.. If there remains a visible line, no matter how faint it may become during test development, the test should be considered negative for the target drug. An extremely faint line could mean that the target drug is near the sensitivity cut-off level for the test. In such circumstances the test could be repeated at another time or a more quantitative method of laboratory testing be employed.
A POSITIVE test result is indicated by the complete absence of a red/pink line at the position indicated for the drug in the test panel. More than one line may be absent indicating a multiple positive drug screen.
An INVALID test result is indicated by the absence of a red/pink line at the (C) or control position.

AVAILABILITY:

The ORAL Q-4™ Saliva Drug Testing System is currently available for point of contact drug of abuse screening in the following configurations. Individual tests in 10 each packs. Standard pack is a dispenser box of twenty five tests. ORAL Q-4™ Saliva Drug Tests are intended for non-diagnostic, forensic use only.

Description	Quantity	Unit	Cost
ORAL Q-4™ Saliva 4 Panel Drug Test	Ten (10) Tests	Each	$79.00
	Twenty-Five (25) Tests	Case	$185.00
	One Hundred (100) Tests	Master Case	$675.00
*If the order buttons are absent or inoperable, please use the pricing overview page to order.